Gattefossé is strengthening its international footprint with the grand opening of its first manufacturing facility in North America. Having established a presence in the US in 1982 with a gross sales workplace in Paramus, New Jersey, and later expanded with the launch of its Technical Heart of Excellence in 2017, the corporate is now taking a decisive step in deepening its presence on the continent.
The Lufkin plant, devoted to lipid-based excipients, was designed with a twin goal: to develop manufacturing capability and to strengthen Gattefossé’s presence in a market that’s strategic for the group in each prescribed drugs and private care. This new facility marks Gattefossé’s largest funding for the reason that firm’s founding in 1880. Lufkin, in East Texas, sits on the crossroads of Dallas, Houston, and Shreveport, making it a strategic logistics hub.
A transformative funding
Designed as a long-term dedication to Gattefossé’s North American clients, the brand new manufacturing web site boosts capability, secures provide chains, and shortens lead occasions — all whereas upholding the identical high-quality requirements because the group’s different manufacturing websites throughout the globe.
In March 2025, the Lufkin plant was awarded three world-class certifications – ISO 9001, EFfCI GMP, and EXCiPACT – recognizing Gattefossé’s rigorous strategy to high quality, security, and compliance in each pharmaceutical and beauty ingredient manufacturing. Along with effectivity and efficiency, the location was designed based on LEED certification standards, guaranteeing it meets the very best environmental requirements.
With this new web site, alongside its historic Saint-Priest manufacturing facility in France and the Singapore facility launched in 2012, Gattefossé now spans three continents. By means of this international industrial community, Gattefossé goals to reinforce provide chain resilience and produce itself nearer to its clients.
“The opening of our new plant in Lufkin marks a significant milestone in our firm’s journey. Selecting the US was a strategic resolution: this area will not be solely a number one market but in addition a worldwide trendsetter in prescribed drugs and private care. This plant is greater than a constructing; it’s a promise to develop, to innovate, and to create worth along with confidence, accountability, and keenness,” stated Ségolène Moyrand-Gros, President of Gattefossé Group.
The inauguration ceremony gathered native and nationwide officers, together with Congressman Pete Classes and Mayor Mark Hicks, alongside Gattefossé executives, clients, companions, staff, and neighborhood members.
“Our partnership with Gattefossé is rooted in historical past, formed by science, and constructed on belief. This new U.S.-based footprint is greater than an operational enlargement, it’s a strong lever for efficiency. By finding nearer to our growth websites and manufacturing hubs, Gattefossé reduces provide danger, strengthens resilience, and ensures real-time collaboration. In our fast-moving world, proximity isn’t a comfort, it’s a aggressive benefit. This funding tells the world that Gattefossé is scaling with objective and strengthening the reliability and high quality of the complete provide chain,” emphasised Diana Trepanier, Vice President Procurement, Pharma & Shopper Well being at Catalent, on this event.
A specialist in lipid chemistry and plant extraction for the private care and pharmaceutical industries, Gattefossé had launched this USD 50 million funding in 2022.
